Absorption |
Blood-Brain Barrier | BBB+ | 0.9979 |
Human Intestinal Absorption | HIA+ | 0.9966 |
Caco-2 Permeability | Caco2+ | 0.8867 |
P-glycoprotein Substrate | Substrate | 0.8631 |
P-glycoprotein Inhibitor | Inhibitor | 0.5435 |
Non-inhibitor | 0.8724 |
Renal Organic Cation Transporter | Inhibitor | 0.6380 |
Distribution |
Subcellular localization | Mitochondria | 0.4895 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7698 |
CYP450 2D6 Substrate | Substrate | 0.9274 |
CYP450 3A4 Substrate | Substrate | 0.7796 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6494 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8866 |
CYP450 2D6 Inhibitor | Inhibitor | 0.6978 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8256 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8899 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7470 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8556 |
Non-inhibitor | 0.8615 |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.9567 |
Fish Toxicity | High FHMT | 0.8941 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8916 |
Honey Bee Toxicity | Low HBT | 0.5107 |
Biodegradation | Not ready biodegradable | 0.9935 |
Acute Oral Toxicity | II | 0.7450 |
Carcinogenicity (Three-class) | Non-required | 0.7141 |